Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/7 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME17334462
PMID: | 17334462
CED: | 20070305
Autoren: | Jawad AS; Irving K
Titel: | Drug treatment modalities in patients with chronic osteoarthritis of the hip or knee.
Quelle: | Saudi medical journal; VOL: 28 (3); p. 375-8 /200703/
PM: | Print
SU: | IM
Sprache: | English
CY: | Saudi Arabia
JID: | 7909441
ISSN: | 0379-5284
CO: | SAMJDI
Institution: | The Royal London Hospital, Bancroft Road, London E1 4DG, United Kingdom. Tel. +44 (208) 2238865. Fax. +44 (208) 2238807. E-mail: alismjawad1@hotmail.com.
DT: | Journal Article
AB: | OBJECTIVE: A survey was conducted to determine drug treatments taken by patients with chronic osteoarthritis (OA) of the hip or knee. METHODS: Data was collected at outpatient clinics at the Royal London and Newham University Hospitals, Bancroft Road, London between November 2001 and February 2003. RESULTS: Two hundred patients (mean age of 65.8 years, mean OA duration of 4.4 years) completed the survey; 175 with OA of knee and 25 with OA of hip. The majority of patients (64%) required a combination of drug treatments, either prescribed or self-medicated, to manage their disease. Of the total patients, 76% were taking paracetamol, 40% were taking an NSAID and 39% were taking complementary therapy (such as cod liver oil or glucosamine) either as monotherapy or in combination with other drugs. Of this patients 39% who previously used an NSAID had discontinued, primarily due to side effects, especially those of the gastrointestinal tract. CONCLUSION: The survey results demonstrate that there is a need to individualize treatment for each patient, which is consistent with published recommendations for the management of OA.

» Volltext »
» Fenster schließen »